These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9442305)

  • 1. Use of transgenic mutational test systems in risk assessment of carcinogens.
    Schmezer P; Eckert C; Liegibel UM; Klein RG; Bartsch H
    Arch Toxicol Suppl; 1998; 20():321-30. PubMed ID: 9442305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of shuttle vectors for mutation analysis in transgenic mice and rats.
    Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM
    Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology.
    Ashby J; Tinwell H
    Mutagenesis; 1994 May; 9(3):179-81. PubMed ID: 7934956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays.
    Morrison V; Ashby J
    Mutagenesis; 1994 Jul; 9(4):367-75. PubMed ID: 7968580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice.
    Lefevre PA; Tinwell H; Galloway SM; Hill R; Mackay JM; Elcombe CR; Foster J; Randall V; Callander RD; Ashby J
    Hum Exp Toxicol; 1994 Nov; 13(11):764-75. PubMed ID: 7857696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of transgenic mice for studying mutagenicity induced by 1,3-butadiene.
    Recio L; Goldsworthy TL
    Toxicol Lett; 1995 Dec; 82-83():607-12. PubMed ID: 8597116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
    Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
    Cunningham ML; Hayward JJ; Shane BS; Tindall KR
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis.
    Provost GS; Mirsalis JC; Rogers BJ; Short JM
    Environ Mol Mutagen; 1996; 28(4):342-7. PubMed ID: 8991062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of mutations in transgenic animal models: BigBlue and Muta Mouse.
    Schmezer P; Eckert C
    IARC Sci Publ; 1999; (146):367-94. PubMed ID: 10353395
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenic activity of carcinogens detected in transgenic rodent mutagenicity assays at dose levels used in chronic rodent cancer bioassays.
    Schmezer P; Eckert C; Liegibel UM; Zelezny O; Klein RG
    Mutat Res; 1998 Sep; 405(2):193-8. PubMed ID: 9748572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens.
    Dean SW; Brooks TM; Burlinson B; Mirsalis J; Myhr B; Recio L; Thybaud V
    Mutagenesis; 1999 Jan; 14(1):141-51. PubMed ID: 10474836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experiences and future directions for transgenic mouse mutation assays.
    Suzuki T; Hayashi M; Sofuni T
    Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen.
    Hoshi M; Morimura K; Wanibuchi H; Wei M; Okochi E; Ushijima T; Takaoka K; Fukushima S
    Toxicol Sci; 2004 Oct; 81(2):273-9. PubMed ID: 15282409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of lacI and lacZ transgenic mouse mutation assays: an EU-sponsored interlaboratory study.
    Tinwell H; Liegibel U; Krebs O; Schmezer P; Favor J; Ashby J
    Mutat Res; 1995 Oct; 335(2):185-90. PubMed ID: 7477049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity.
    Suzuki T; Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T
    Mutat Res; 1998 Jan; 412(2):161-6. PubMed ID: 9539970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses.
    Tinwell H; Lefevre PA; Ashby J
    Mutat Res; 1994 May; 307(1):169-73. PubMed ID: 7513794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.